Who is sponsoring NCT06255210?

NCT06255210 is sponsored by Hongmeng Yu.

What drugs are being tested in NCT06255210?

Interventions in NCT06255210: Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP).

What condition does NCT06255210 study?

NCT06255210 studies Olfactory Neuroblastoma.

Is NCT06255210 still recruiting?

NCT06255210 is currently recruiting now. Last updated 13 February 2024.

Last reviewed 2024-02-13 · How we verify

NCT06255210: ESICON

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)

Recruiting now Phase 2 Last updated 13 February 2024

What this trial tests

Phase 2 trial testing Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP) in Olfactory Neuroblastoma in 25 participants. Currently enrolling.

Timeline

1 March 2024

Primary endpoint
1 March 2027

1 March 2030

Quick facts

Lead sponsor	Hongmeng Yu
Phase	Phase 2
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	1 March 2024
Primary completion	1 March 2027
Estimated completion	1 March 2030
Sites	1 location across China

Drugs / interventions tested

Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP) — full drug profile →

Conditions studied

Olfactory Neuroblastoma — all drugs for Olfactory Neuroblastoma →

Sponsor

Hongmeng Yu — full company profile →

Who can join

18 and older, any sex, with Olfactory Neuroblastoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about the induction chemotherapy efficacy in olfactory neuroblastoma. The main question it aims to answer is: wether olfactory neuroblastoma patients with different pathology subtypes apply to different induction chemotherapy schemes. Participants will be treated with different chemotherapy schemes, to evaluate the tumor remission rate and long term survival.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Olfactory Neuroblastoma

Currently open trials in the same condition.

NCT04755205 — A Natural History Study of Children and Adults With Olfactory Neuroblastoma · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06255210 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hongmeng Yu
Last refreshed: 13 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06255210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing